Illumina News and Research

RSS

New Omicron subvariant BA.2.86: A master of immune escape but not taking over yet

Researchers have isolated a new SARS-CoV-2 Omicron subvariant, BA.2.86, revealing its ability to escape neutralizing antibodies five-fold greater than its ancestor strain. Despite its enhanced immune evasion capabilities, BA.2.86 has not shown a significant difference in spread compared to other current variants.

13 Sep 2023

How did COVID-19 pandemic restrictions impact invasive meningococcal disease trends?

The impact of COVID-19 pandemic restrictions on the incidence and strain distribution of meningococcus.

11 Sep 2023

Early viral exposure in mice weakens vaccine response, raising questions for human studies

Researchers at Washington University have demonstrated that early life exposure to multiple viruses in house mice dampens the immune response to SARS-CoV-2 vaccinations later in life. The study raises concerns about the applicability of common mouse models in immunological research, suggesting that prior pathogen exposure could be a significant variable in predicting vaccine efficacy.

5 Sep 2023

Illumina's board appoints Jacob Thaysen, Ph.D. as its new Chief Executive Officer

llumina today announced that its Board of Directors has appointed Jacob Thaysen, Ph.D., as Chief Executive Officer, effective September 25, 2023.

From Illumina, Inc. 5 Sep 2023

Maternal obesity linked to childhood weight issues through DNA changes

Boston Birth Cohort study finds that maternal pre-pregnancy obesity alters newborn DNA methylation, potentially increasing the risk of obesity in the child. The research targets high-risk U.S. demographics and could guide future interventions for childhood obesity.

27 Aug 2023

The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer, and Merck

Illumina Inc., a global leader in DNA sequencing and array-based technologies, in collaboration with Nashville Biosciences, LLC, a leading clinical and genomic data company and wholly owned subsidiary of VUMC, today announced the five founding members of the Alliance for Genomic Discovery.

17 Aug 2023

Evolutionary roadmap revealed: How SARS-CoV-2 adapted and evolved over three years

The evolutionary trends of amino acid alterations at a population scale.

16 Aug 2023

A blood test that screens for cancer: Does it do more harm than good?

By summer 2021, Gilbert Milam Jr. was living a good life. A nationally renowned rapper who performs under the name Berner, Milam was also enjoying the global expansion of Cookies, a brand of cannabis products and clothing that he co-founded and was running as CEO.

11 Aug 2023

Uncommon genetic allele variants may play a vital role in treatment-resistant depression, finds study

The association between treatment-resistant depression and uncommon functional genetic alleles.

3 Aug 2023

New research sheds light on gut-kidney axis in diabetes and diabetic nephropathy

Researchers explored gut microbiota composition to evaluate the association between the microbes and diabetic clinical phenotypes.

2 Aug 2023

More steps linked to improved health for heart failure patients

Merck awards 2023 Future Insight Prize for research into air sensor to detect pandemic pathogens

Merck KGaA, Darmstadt, Germany, awarded its 2023 Future Insight Prize to Khalid Salaita, professor of chemistry at Emory University. The award comes with $540,000 to fund the next phase of research into an air sensor that can continuously monitor indoor spaces for pathogens that can cause pandemics.

17 Jul 2023

Illumina News and Research

New Omicron subvariant BA.2.86: A master of immune escape but not taking over yet

How did COVID-19 pandemic restrictions impact invasive meningococcal disease trends?

Early viral exposure in mice weakens vaccine response, raising questions for human studies

Illumina's board appoints Jacob Thaysen, Ph.D. as its new Chief Executive Officer

Maternal obesity linked to childhood weight issues through DNA changes

The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer, and Merck

Evolutionary roadmap revealed: How SARS-CoV-2 adapted and evolved over three years

A blood test that screens for cancer: Does it do more harm than good?

Uncommon genetic allele variants may play a vital role in treatment-resistant depression, finds study

New research sheds light on gut-kidney axis in diabetes and diabetic nephropathy

More steps linked to improved health for heart failure patients

Merck awards 2023 Future Insight Prize for research into air sensor to detect pandemic pathogens

Aerobic glycolysis essential for eye development in mammals, study finds

Exploring the relationship between epigenetic aging and gut microbiome composition in physically fit men and women

New computational technique shows promise for identifying different subtypes of Alzheimer's disease

New data demonstrates severe AMR among non-typhoidal Salmonella isolated from food in China

New variants of human metapneumovirus surge in Spain post-COVID, highlighting evolution and impact

Biosensor Versatility; From Analytical Chemistry to Diagnostics

Research sheds light on the early cellular events that give rise to pancreatic cancer

Study pinpoints how gut microbes boost the body's response to cancer immunotherapy

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News